Poseida Therapeutics Inc (PSTX)
9.44
-0.03
(-0.32%)
USD |
NASDAQ |
Dec 23, 15:10
Poseida Therapeutics Cash from Investing (Quarterly): 27.65M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Galectin Therapeutics Inc | -- |
| Revance Therapeutics Inc | 23.29M |
| Sage Therapeutics Inc | 81.05M |
| Alector Inc | 40.35M |
| Phathom Pharmaceuticals Inc | -0.044M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.594M |
| Cash from Financing (Quarterly) | 0.742M |
| Free Cash Flow | -17.13M |
| Free Cash Flow Per Share (Quarterly) | -0.1042 |
| Free Cash Flow to Equity (Quarterly) | -10.35M |
| Free Cash Flow to Firm (Quarterly) | -7.949M |
| Free Cash Flow Yield | -1.88% |